Media
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
UCB Partners with Ailux, a Division of XtalPi, on Biologics Al Platform
Ailux, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform
Introducing Ailux by XtalPi
Ailux Selected for Digital Oral and Poster Presentations at ECCO’26, Highlighting Potential for Novel IBD Treatment
Antibody Engineering & Therapeutics 2025 USA
PEGS Europe 2025
Ailux Announces Posters at American College of Rheumatology (ACR) Convergence 2025
PEGS Boston 2025
Antibody Engineering & Therapeutics 2024 USA
PEGS Europe 2024